WebApr 9, 2024 · Clarus Therapeutics (OTCMKTS:CRXTQ) has a market capitalization of $52,020.00 and generates $13.96 million in revenue each year. The company earns $ … WebAug 11, 2024 · The Company plans to continue to solicit proxies from stockholders during the period prior to the Special Meeting. Only the holders of Blue Water's common stock …
Blue Water Stockholders Approve Clarus Therapeutics Deal
WebMay 26, 2024 · About Clarus Therapeutics, Inc. Clarus is a pharmaceutical company with expertise and interest in developing androgen and metabolic therapies for men and women – including potential therapies ... WebApr 27, 2024 · Existing Clarus stakeholders, led by H. I. G. Capital, will invest an additional $25 million in Clarus following the announcement of this transaction, which investment … tabletop simulator dungeon crawl
Clarus Therapeutics plunges 22% on equity offering - SeekingAlpha
WebFeb 28, 2024 · Item 7.01 Regulation FD Disclosure. As previously disclosed, on September 5, 2024, Clarus Therapeutics Holdings, Inc., or Clarus, and its wholly-owned subsidiary Clarus Therapeutics, Inc., or OpCo, filed voluntary petitions for bankruptcy protection under Chapter 11 of Title 11 of the United States Bankruptcy Code.The filing was made in the … WebApr 27, 2024 · Clarus Therapeutics shareholders and Blue Water Acquisition Corp. shareholders will hold shares in Clarus Therapeutics, which is expected to be listed on … WebFeb 24, 2024 · Share this article. NORTHBROOK, Ill., Feb. 24, 2024 /PRNewswire/ -- Clarus Therapeutics Inc. announced today the appointment of Richard 'Ric' Peterson as chief financial officer (CFO). Peterson ... tabletop simulator dungeon walls